GEN2h
Next-Gen Cas12a System Enables Precise Single and Multiplexed Gene Editing in Cancer
Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.
£1.65m gene-editing therapy offers hope of cure for some blood disorder patients
A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...
Complex engineering of human cell lines reveals genome's unexpected resilience to structural changes
The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...
American Association of Individual Investors2d
Which Is a Better Investment, Legend Biotech Corporation or Twist Bioscience Corporation Stock?
Learn more about whether Legend Biotech Corporation or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
American Association of Individual Investors2d
Which Is a Better Investment, Twist Bioscience Corporation or Veracyte, Inc. Stock?
Learn more about whether Twist Bioscience Corporation or Veracyte, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.